LXFR vs PHOE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LXFR presents a conflicted profile with a stable Piotroski F-Score of 4/9 and a significant valuation gap, as the current price of $14.24 trades well above the Graham Number ($9.58) and Intrinsic Value ($3.36). While the company demonstrates a strong track record of earnings surprises and maintains a very healthy debt-to-equity ratio (0.23), these are offset by contracting revenues (-12.30% YoY) and an unsustainable dividend payout ratio of 108.33%. The stock is currently priced for a recovery that is not yet reflected in the top-line growth, though the forward P/E of 11.30 suggests expected earnings improvement.
PHOE exhibits a stable financial health profile with a Piotroski F-Score of 5/9 and a debt-free balance sheet, but it is fundamentally decoupled from its valuation. The stock trades at an astronomical P/E of 586.67 and a Price/Book of 50.72, while the Graham Number ($0.48) and Intrinsic Value ($0.21) suggest the current price of $17.60 is an extreme speculative premium. With revenue declining by 7.3% and earnings crashing by 76.1% YoY, there is no fundamental growth driver to justify the current market price.
Compare Another Pair
Related Comparisons
LXFR vs PHOE: Head-to-Head Comparison
This page compares Luxfer Holdings PLC (LXFR) and Phoenix Asia Holdings Limited (PHOE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.